411 A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies
A.P. Moore, S. Thomas, C.J. Ryan, T.M. Jahan, S.G. DuBois, J.K. Chan, K.T. Thurn, A. Reinhert, A. Daud, P.N. MunsterVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)72118-2
File:
PDF, 65 KB
english, 2010